Drug Profile
Hydrocodone/chlorpheniramine - Currax Pharmaceuticals
Alternative Names: Chlorpheniramine/hydrocodone - Currax Pharmaceuticals; VituzLatest Information Update: 09 May 2019
Price :
$50
*
At a glance
- Originator Cypress Pharmaceutical
- Developer Currax Pharmaceuticals
- Class Antiallergics; Antitussives; Morphinans; Opioid analgesics; Sedating antihistamines
- Mechanism of Action Histamine H1 receptor antagonists; Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Common cold; Cough